CC
Callan Capital Portfolio holdings
AUM
$1.35B
1-Year Return
8.35%
This Quarter Return
+7.2%
1 Year Return
+8.35%
3 Year Return
+20.11%
5 Year Return
+98.58%
10 Year Return
+94.69%
AUM
$1.43B
AUM Growth
+$216M
(+18%)
Cap. Flow
+$140M
Cap. Flow
% of AUM
9.78%
Top 10 Holdings %
Top 10 Hldgs %
48.22%
Holding
359
New
46
Increased
193
Reduced
88
Closed
11
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$127M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$4.06M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$3.72M |
| 4 |
Avantis US Small Cap Value ETF
AVUV
|
$3.3M |
| 5 |
Rubrik
RBRK
|
$1.51M |
Top Sells
| 1 |
Schwab International Equity ETF
SCHF
|
$3.01M |
| 2 |
Apple
AAPL
|
$2.86M |
| 3 |
Schwab Fundamental International Large Company Index ETF
FNDF
|
$2.07M |
| 4 |
Home BancShares
HOMB
|
$1.67M |
| 5 |
Becton Dickinson
BDX
|
$1.66M |
Sector Composition
| 1 | Communication Services | 10.71% |
| 2 | Technology | 6.97% |
| 3 | Healthcare | 2.63% |
| 4 | Financials | 1.83% |
| 5 | Consumer Discretionary | 1.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Schwab US Dividend Equity ETF
SCHD
$71.8B
| $278K | 0.02% |
9,876
-9,678
| -49% | -$273K |
|
277
Charles Schwab
SCHW
$167B
| $278K | 0.02% |
4,287
-1,267
| -23% | -$82.1K |
|
|
MRO
278
DELISTED
Marathon Oil Corporation
MRO
| $276K | 0.02% |
10,372
-101
| -1% | -$2.69K |
|
279
GSK
GSK
$81.5B
| $276K | 0.02% |
6,747
-151
| -2% | -$6.17K |
|
280
Molson Coors Class B
TAP
$9.96B
| $275K | 0.02% |
+4,787
| New | +$275K |
|
281
United Parcel Service
UPS
$72.1B
| $271K | 0.02% |
+1,989
| New | +$271K |
|
282
L3Harris
LHX
$51B
| $266K | 0.02% |
1,117
-478
| -30% | -$114K |
|
283
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.58B
| $263K | 0.02% |
11,986
| – | – |
|
|
AGR
284
DELISTED
Avangrid, Inc.
AGR
| $263K | 0.02% |
7,341
+516
| +8% | +$18.5K |
|
285
iShares US Technology ETF
IYW
$23.1B
| $260K | 0.02% |
1,714
| – | – |
|
286
AerCap
AER
$22B
| $259K | 0.02% |
2,737
+334
| +14% | +$31.6K |
|
287
Colgate-Palmolive
CL
$68.8B
| $259K | 0.02% |
2,497
+168
| +7% | +$17.4K |
|
288
American Tower
AMT
$92.9B
| $255K | 0.02% |
1,096
-42
| -4% | -$9.77K |
|
289
Smith & Nephew
SNN
$16.5B
| $254K | 0.02% |
+8,157
| New | +$254K |
|
290
Jones Lang LaSalle
JLL
$14.8B
| $253K | 0.02% |
+939
| New | +$253K |
|
291
Gilead Sciences
GILD
$143B
| $253K | 0.02% |
3,017
-2,282
| -43% | -$191K |
|
292
Principal Investment Grade Corporate Active ETF
IG
$122M
| $252K | 0.02% |
11,762
| – | – |
|
293
Scotiabank
BNS
$78.8B
| $249K | 0.02% |
+4,575
| New | +$249K |
|
294
Corning
GLW
$61B
| $249K | 0.02% |
5,506
+164
| +3% | +$7.41K |
|
295
Amphenol
APH
$135B
| $246K | 0.02% |
3,780
+688
| +22% | +$44.8K |
|
296
Qiagen
QGEN
$10.3B
| $246K | 0.02% |
+5,239
| New | +$246K |
|
297
Cardiff Oncology
CRDF
$144M
| $244K | 0.02% |
91,467
+26,420
| +41% | +$70.5K |
|
298
Intercontinental Exchange
ICE
$99.8B
| $243K | 0.02% |
+1,515
| New | +$243K |
|
299
SPDR Dow Jones Industrial Average ETF Trust
DIA
$39.8B
| $243K | 0.02% |
575
-95
| -14% | -$40.2K |
|
300
Amdocs
DOX
$9.46B
| $242K | 0.02% |
+2,762
| New | +$242K |
|